{"id":"https://openalex.org/W2129809363","doi":"https://doi.org/10.1161/circresaha.115.307071","title":"Effects of Evolocumab on Vitamin E and Steroid Hormone Levels: Results From the 52-Week, Phase 3, Double-Blind, Randomized, Placebo-Controlled DESCARTES Study","display_name":"Effects of Evolocumab on Vitamin E and Steroid Hormone Levels: Results From the 52-Week, Phase 3, Double-Blind, Randomized, Placebo-Controlled DESCARTES Study","alternate_titles":[],"publication_year":2015,"publication_date":"2015-07-31","ids":{"openalex":"https://openalex.org/W2129809363","doi":"https://doi.org/10.1161/circresaha.115.307071","mag":"2129809363","pmid":"https://pubmed.ncbi.nlm.nih.gov/26228031"},"language":"en","primary_location":{"id":"doi:10.1161/circresaha.115.307071","doi":"https://doi.org/10.1161/circresaha.115.307071","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circresaha.115.307071","pdf_url":null,"source":{"id":"https://openalex.org/S10652568","display_name":"Circulation Research","issn_l":"0009-7330","issn":["0009-7330","1524-4571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2129809363"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078515650","display_name":"Dirk Jacobus Blom","orcid":"https://orcid.org/0000-0003-3965-5912","observed_orcids":["https://orcid.org/0000-0003-3965-5912"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["ZA"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Dirk J. Blom","raw_affiliation_strings":["Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa","Dirk J. Blom From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274"]},{"raw_affiliation_string":"Dirk J. Blom From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.)","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004271735","display_name":"C. Stephen Djedjos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["US","ZA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Stephen Djedjos","raw_affiliation_strings":["Cardiovascular Therapeutic Area, Amgen Inc, Thousand Oaks, CA","C. Stephen Djedjos From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Therapeutic Area, Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"C. Stephen Djedjos From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.)","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052274869","display_name":"Maria Laura Monsalvo","orcid":"https://orcid.org/0000-0002-4113-9418","observed_orcids":["https://orcid.org/0000-0002-4113-9418"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["US","ZA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria Laura Monsalvo","raw_affiliation_strings":["Cardiovascular Therapeutic Area, Amgen Inc, Thousand Oaks, CA","Maria Laura Monsalvo From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Therapeutic Area, Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Maria Laura Monsalvo From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.)","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049941770","display_name":"Ian M. Bridges","orcid":"https://orcid.org/0000-0002-3317-3528","observed_orcids":["https://orcid.org/0000-0002-3317-3528"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]},{"id":"https://openalex.org/I4210117596","display_name":"Amgen (United Kingdom)","ror":"https://ror.org/02gvvc992","country_code":"GB","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210117596"]}],"countries":["GB","ZA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ian Bridges","raw_affiliation_strings":["Biostatistics-International, Amgen Ltd, Uxbridge, United Kingdom","Ian Bridges From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics-International, Amgen Ltd, Uxbridge, United Kingdom","institution_ids":["https://openalex.org/I4210117596"]},{"raw_affiliation_string":"Ian Bridges From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.)","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086317157","display_name":"Scott M. Wasserman","orcid":"https://orcid.org/0000-0003-0634-6021","observed_orcids":["https://orcid.org/0000-0003-0634-6021"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["US","ZA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Scott M. Wasserman","raw_affiliation_strings":["Cardiovascular Therapeutic Area, Amgen Inc, Thousand Oaks, CA","Scott M. Wasserman From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Therapeutic Area, Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Scott M. Wasserman From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.)","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064971349","display_name":"Robert C. Scott","orcid":"https://orcid.org/0000-0001-8266-1061","observed_orcids":["https://orcid.org/0000-0001-8266-1061"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["US","ZA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rob Scott","raw_affiliation_strings":["Cardiovascular Therapeutic Area, Amgen Inc, Thousand Oaks, CA","Rob Scott From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular Therapeutic Area, Amgen Inc, Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]},{"raw_affiliation_string":"Rob Scott From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.)","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089409959","display_name":"Eli M. Roth","orcid":"https://orcid.org/0000-0002-3367-5704","observed_orcids":["https://orcid.org/0000-0002-3367-5704"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]},{"id":"https://openalex.org/I4210090186","display_name":"Sterling Research Group","ror":"https://ror.org/009prea33","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210090186"]}],"countries":["US","ZA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eli Roth","raw_affiliation_strings":["President, Sterling Research Group, Cincinnati, OH","Eli Roth From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"President, Sterling Research Group, Cincinnati, OH","institution_ids":["https://openalex.org/I4210090186"]},{"raw_affiliation_string":"Eli Roth From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa (D.J.B.)","institution_ids":["https://openalex.org/I157614274"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5078515650"],"corresponding_institution_ids":["https://openalex.org/I157614274"],"apc_list":null,"apc_paid":null,"fwci":9.2007,"has_fulltext":true,"cited_by_count":91,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98581179,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"117","issue":"8","first_page":"731","last_page":"741"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10445","display_name":"Antioxidant Activity and Oxidative Stress","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/evolocumab","display_name":"evolocumab","score":1.0},{"id":"https://openalex.org/keywords/vitamin-e","display_name":"vitamin E","score":0.9760000109672546},{"id":"https://openalex.org/keywords/steroid-hormones","display_name":"steroid hormones","score":0.8560000061988831},{"id":"https://openalex.org/keywords/cortisol","display_name":"cortisol","score":0.9120000004768372},{"id":"https://openalex.org/keywords/acth","display_name":"ACTH","score":0.9950000047683716},{"id":"https://openalex.org/keywords/gonadal-hormones","display_name":"gonadal hormones","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.75},{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.8299999833106995},{"id":"https://openalex.org/keywords/low-ldl-cholesterol","display_name":"low LDL cholesterol","score":0.5759999752044678},{"id":"https://openalex.org/keywords/vitamin-e-transport","display_name":"vitamin E transport","score":0.6460000276565552},{"id":"https://openalex.org/keywords/steroidogenesis","display_name":"steroidogenesis","score":0.6570000052452087},{"id":"https://openalex.org/keywords/high-density-lipoprotein","display_name":"high-density lipoprotein","score":0.7289999723434448}],"concepts":[{"id":"https://openalex.org/C2778114629","wikidata":"https://www.wikidata.org/wiki/Q15623825","display_name":"Evolocumab","level":5,"score":0.9045886993408203},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8070775270462036},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7952642440795898},{"id":"https://openalex.org/C2780546910","wikidata":"https://www.wikidata.org/wiki/Q185690","display_name":"Adrenocorticotropic hormone","level":3,"score":0.7390801310539246},{"id":"https://openalex.org/C124490489","wikidata":"https://www.wikidata.org/wiki/Q7936963","display_name":"Vitamin D and neurology","level":2,"score":0.49241888523101807},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4814314544200897},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.468326598405838},{"id":"https://openalex.org/C2777551382","wikidata":"https://www.wikidata.org/wiki/Q141180","display_name":"Vitamin E","level":3,"score":0.4413858950138092},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.4213360548019409},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41245827078819275},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.3526802062988281},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3161779046058655},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.11113324761390686},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.057348012924194336},{"id":"https://openalex.org/C2780745583","wikidata":"https://www.wikidata.org/wiki/Q1316030","display_name":"Apolipoprotein A1","level":4,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000324","descriptor_name":"Adrenocorticotropic Hormone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006854","descriptor_name":"Hydrocortisone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012697","descriptor_name":"Serine Endopeptidases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012739","descriptor_name":"Gonadal Steroid Hormones","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014810","descriptor_name":"Vitamin E","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043484","descriptor_name":"Proprotein Convertases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D043484","descriptor_name":"Proprotein Convertases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1161/circresaha.115.307071","doi":"https://doi.org/10.1161/circresaha.115.307071","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circresaha.115.307071","pdf_url":null,"source":{"id":"https://openalex.org/S10652568","display_name":"Circulation Research","issn_l":"0009-7330","issn":["0009-7330","1524-4571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation Research","raw_type":"journal-article"},{"id":"pmid:26228031","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26228031","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation research","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W20107991","https://openalex.org/W1520609538","https://openalex.org/W1534530371","https://openalex.org/W1964590451","https://openalex.org/W1967374466","https://openalex.org/W1969197106","https://openalex.org/W1975903914","https://openalex.org/W1978888528","https://openalex.org/W1979534200","https://openalex.org/W1981065823","https://openalex.org/W1985160889","https://openalex.org/W2001255173","https://openalex.org/W2006140375","https://openalex.org/W2009054630","https://openalex.org/W2011163179","https://openalex.org/W2011664867","https://openalex.org/W2016615313","https://openalex.org/W2027932918","https://openalex.org/W2028279889","https://openalex.org/W2032598877","https://openalex.org/W2035815167","https://openalex.org/W2043461445","https://openalex.org/W2044837656","https://openalex.org/W2050245455","https://openalex.org/W2050535391","https://openalex.org/W2053710703","https://openalex.org/W2054347919","https://openalex.org/W2059331100","https://openalex.org/W2064945315","https://openalex.org/W2075556297","https://openalex.org/W2078294084","https://openalex.org/W2080658740","https://openalex.org/W2083247911","https://openalex.org/W2092054388","https://openalex.org/W2106814701","https://openalex.org/W2114728551","https://openalex.org/W2119475560","https://openalex.org/W2127445212","https://openalex.org/W2137740162","https://openalex.org/W2141962901","https://openalex.org/W2152520805","https://openalex.org/W2154022201","https://openalex.org/W2154299504","https://openalex.org/W2155259933","https://openalex.org/W2163488353","https://openalex.org/W2164089346","https://openalex.org/W2165140407","https://openalex.org/W2165275486","https://openalex.org/W2166384708","https://openalex.org/W2169935588","https://openalex.org/W2188670071","https://openalex.org/W2408241348","https://openalex.org/W2415092010","https://openalex.org/W2436231384","https://openalex.org/W3021363219"],"related_works":["https://openalex.org/W2413122988","https://openalex.org/W1660877337","https://openalex.org/W2942654605","https://openalex.org/W7202161993","https://openalex.org/W1454136159","https://openalex.org/W3136335535","https://openalex.org/W2326731481","https://openalex.org/W7000223038","https://openalex.org/W4377564544","https://openalex.org/W4413268466"],"abstract_inverted_index":{"RATIONALE:":[0],"Vitamin":[1,68,204],"E":[2,33,88,110,134,155,205,225],"transport":[3],"and":[4,14,34,73,80,98,105,149,174,206,218],"steroidogenesis":[5],"are":[6],"closely":[7],"associated":[8],"with":[9,52,237],"low-density":[10],"lipoproteins":[11],"(LDLs)":[12],"metabolism,":[13],"evolocumab":[15,30],"can":[16],"lower":[17],"LDL":[18],"cholesterol":[19],"(LDL-C)":[20],"to":[21,59,117,139,168,201,229],"low":[22,252],"levels.":[23,37,254],"OBJECTIVE:":[24],"To":[25],"determine":[26],"the":[27,131,143,146,175],"effects":[28,241],"of":[29,43,62],"on":[31],"vitamin":[32,87,109,133,154,224],"steroid":[35,207,245],"hormone":[36,173,177,187],"METHODS":[38],"AND":[39],"RESULTS:":[40],"After":[41],"titration":[42],"background":[44],"lipid-lowering":[45],"therapy":[46],"per":[47],"cardiovascular":[48],"risk,":[49],"901":[50],"patients":[51,114,163,232],"an":[53],"LDL-C":[54,216,253],"\u22652.0":[55],"mmol/L":[56],"were":[57,76,90,209,242],"randomized":[58],"52":[60,119,141,235],"weeks":[61,236],"monthly,":[63],"subcutaneous":[64],"evolocumab,":[65],"or":[66,246],"placebo.":[67],"E,":[69],"cortisol,":[70],"adrenocorticotropic":[71,172],"hormone,":[72],"gonadal":[74,194,247],"hormones":[75,195],"analyzed":[77],"at":[78,103,250],"baseline":[79,104,116,138,167,200],"week":[81,106,118,140,169,202],"52.":[82,107,203],"In":[83,130],"a":[84,185],"substudy":[85],"(n=100),":[86],"levels":[89,156,226],"also":[91],"measured":[92],"in":[93,112,145,161,244],"serum,":[94],"LDL,":[95],"high-density":[96],"lipoprotein,":[97],"red":[99,150],"blood":[100,151],"cell":[101,152],"membranes":[102],"Absolute":[108],"decreased":[111],"evolocumab-treated":[113,162,192],"from":[115,137,166,199],"by":[120,124,213],"16%":[121],"but":[122,171],"increased":[123,164],"19%":[125],"when":[126],"normalized":[127],"for":[128,234],"cholesterol.":[129],"substudy,":[132],"level":[135],"changes":[136,144,208],"mirrored":[142],"lipid":[147],"fraction,":[148],"membrane":[153],"did":[157,179,196],"not":[158,180,197],"change.":[159,181],"Cortisol":[160],"slightly":[165],"52,":[170],"cortisol:adrenocorticotropic":[176,186],"ratio":[178,188],"No":[182,239],"patient":[183],"had":[184],"<3.0":[189],"(nmol/pmol).":[190],"Among":[191],"patients,":[193],"change":[198],"consistent":[210],"across":[211],"subgroups":[212],"minimum":[214],"postbaseline":[215],"<0.4":[217],"<0.6":[219],"mmol/L.":[220],"CONCLUSIONS:":[221],"As":[222],"expected,":[223],"changed":[227],"similarly":[228],"lipids":[230],"among":[231],"treated":[233],"evolocumab.":[238],"adverse":[240],"observed":[243],"hormones,":[248],"even":[249],"very":[251],"CLINICAL":[255],"TRIAL":[256],"REGISTRATION:":[257],"URL:":[258],"http://www.clinicaltrials.gov.":[259],"Unique":[260],"identifier:":[261],"NCT01516879.":[262]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2129809363","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":17},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
